Related Experiment Video
Updated: Jul 8, 2026
07:27
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Congestive heart failure associated with itraconazole
Lancet (London, England)
|June 14, 2001
Summary
Itraconazole, an antifungal, may cause congestive heart failure. This risk is highlighted by 58 reported cases, leading to updated physician warnings for this important antifungal medication.
Area of Science:
- Pharmacology
- Cardiology
- Infectious Diseases
Background:
- Itraconazole is a synthetic antifungal medication used for onychomycosis and systemic fungal infections.
- Pharmacological studies indicate that itraconazole may exert negative inotropic effects.
- The US Food and Drug Administration's Adverse Event Reporting System (FAERS) data has flagged potential associations between itraconazole use and congestive heart failure.
Discussion:
- This summary details 58 cases suggesting a link between itraconazole and congestive heart failure.
- The observed cases provide further evidence for the cardiovascular risks associated with itraconazole.
- Healthcare providers should be aware of these potential cardiac adverse events.
Key Insights:
- Itraconazole use is associated with an increased risk of congestive heart failure.
- A review of 58 cases supports a link between this antifungal and cardiac events.
- Updated drug labeling now alerts physicians to this significant safety concern.
Outlook:
- Further research may explore the precise mechanisms behind itraconazole-induced cardiotoxicity.
- Enhanced monitoring protocols for patients on itraconazole may be warranted.
- This finding underscores the importance of pharmacovigilance in identifying drug-related adverse events.
More Related Videos
Related Concept Videos
01:26Imbalances in Cardiac Output
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
01:27Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
01:26Heart Failure III: Clinical Manifestations
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...